CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net loss	$ (11,940)	$ (8,139)
Adjustments to reconcile net loss to net cash flows provided by (used in) operating activities:
Depreciation and amortization	37,099	40,250
Amortization of deferred loan costs	1,481	1,390
Amortization of debt discount	5,308	5,018
Share-based employee compensation expense	7,539	5,867
Equity in loss from joint ventures	20,443	0
Deferred income taxes	(8,046)	(6,464)
Excess tax benefits from share-based payment arrangements	0	(340)
Decrease (increase) in accounts receivable, net	1,828	(25,482)
Decrease in other current assets	558	1,867
Increase (decrease) in accounts payable	1,281	(7,591)
Decrease in accrued salaries and benefits	(6,518)	(3,404)
(Decrease) increase in other current liabilities	(7,216)	20,561
Other	(2,990)	8,786
Net cash flows provided by operating activities	38,827	32,319
Cash flows from investing activities:
Acquisition of property and equipment	(26,390)	(31,927)
Investment in joint ventures	(6,075)	(5,425)
Other	(851)	(893)
Net cash flows used in investing activities	(33,316)	(38,245)
Cash flows from financing activities:
Proceeds from issuance of long-term debt	461,456	350,750
Payments of long-term debt	(468,334)	(357,962)
Deferred loan costs	0	(88)
Excess tax benefits from share-based payment arrangements	0	340
Exercise of stock options	2,464	1,498
Repurchase of common stock	(1,833)	0
Proceeds from non-controlling Interests	1,615	0
Change in cash overdraft and other	1,005	11,221
Net cash flows (used in) provided by financing activities	(3,627)	5,759
Effect of exchange rate changes on cash	(1,884)	(709)
Net increase (decrease) in cash and cash equivalents	0	(876)
Cash and cash equivalents, beginning of period	1,765	2,584
Cash and cash equivalents, end of period	$ 1,765	$ 1,708